Pilot study to investigate the impacts of cannabinoids from industrial hemp and repeated transportation events on cattle health and immune status

Authors

  • B. R. Fritz Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • M. D. Kleinhenz Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • J. Griffin John C. Pair Horticulture Center, Kansas State University, 1901 East 95th St South, Haysville, KS 67060
  • M. Weeder Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • A. A. Leslie Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • B. T. Johnson Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, 66506
  • A. K. Curtis Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506
  • J. F. Coetzee Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506

DOI:

https://doi.org/10.21423/aabppro20228692

Abstract

The segmentation of the cattle industries necessitates regular transportation. Transport alters immune and stress biomark­ers in cattle. The passage of the 2018 Farm Bill excluded indus­trial hemp (IH; Cannabis sativa, ≤ 0.3% tetrahydrocannabinol) from the USDA marijuana definition and DEA Schedule I sta­tus, enabling USDA-authorized IH research to determine the sustainability of IH cultivation. Data on the utility of IH for cattle transport has not been described. The object of the cur­rent study was to evaluate the effects of oral IH on immune and stress biomarkers in cattle being transported considerable distances.

Downloads

Published

2023-07-17

Issue

No. 55 (2022): 2022 Annual Conference Proceedings

Section

Research Summaries